Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma.
Kristen M SanfilippoKenneth R CarsonTzu-Fei WangSuhong LuoNatasha EdwinNicole M KudererJesse M KellerBrian F GagePublished in: Research and practice in thrombosis and haemostasis (2022)
In conclusion, in this cohort of 2870 patients with MM, the Khorana score did not predict VTE. Our study supports the need to use myeloma-specific risk models to predict VTE risk in patients with MM.